The Global Bronchiolitis Obliterans Syndrome Market is driven by increasing prevalence of respiratory diseases
Bronchiolitis obliterans, commonly known as obliterative bronchiolitis, is a chronic lung disease characterized by inflammation and fibrosis of the small airways of lungs leading to progressive shortness of breath. It is caused due to inhalation of noxious gases, smoke fumes or air pollutants. Growing industrialization and rising air pollution levels have contributed significantly to the rising incidence of respiratory conditions including bronchiolitis obliterans. Products used in the treatment of bronchiolitis obliterans include bronchodilators, antibiotics and steroids which help in reducing the airway inflammation and managing the symptoms.
The bronchiolitis obliterans syndrome market is estimated to be valued at USD 60.37 Mn in 2024 and is expected to reach USD 79.93 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2031.
Increasing air pollution levels worldwide is a key factor driving the Bronchiolitis Obliterans Syndrome Market. Automobile exhaust, industrial effluents and smoke emitted from thermal power plants release large amounts of tiny air pollutants that can damage the lung airways when inhaled over time. Growing consumption of tobacco products is another major driver as cigarette smoke is a well-established risk factor for bronchiolitis obliterans. According to the WHO, tobacco kills over 8 million people globally every year with majority deaths occurring due to respiratory diseases.
Get More Insights On- Bronchiolitis Obliterans Syndrome Market
Get This Report in Japanese Language: 閉塞性細気管支炎症候群市場
Get This Report in Korean Language: 세기관지염 폐쇄증후군 시장
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian